News & Media

Press Releases

22 October 2024

Lohocla Research Recognized as a Leader in Innovation with a 2024 Colorado Inno Award from the Denver Business Journal
Local biotech firm is one of ten companies recognized for “their out-of-the-box thinking and inventive products and services.”

28 May 2024

Lohocla Research Embarks Upon Phase 1 Human Trials with Its First-in-class Medication for Treating Chronic Pain
Lohocla Research Corporation begins first-in-human trials of their ground-breaking therapeutic for chronic pain syndromes.

13 March 2024

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Nezavist, a Novel Medicinal Molecule for Treating Addiction and Craving
Focusing on non-addictive treatments for chronic pain and addiction, Lohocla Research Corporation gets the go-ahead for first-in-human trials of their first-in-class therapeutic for alcohol use disorder.

31 October 2023

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain
Focusing on non-addictive treatments for chronic pain and addiction, Lohocla Research Corporation gets the go-ahead for first-in-human trials of their first-in-class therapeutic for chronic pain syndromes.

20 July 2021

Local Biotech Firm Receives NIH Funding for First-in-Human Trials for Opiate-Sparing Drug for Chronic Pain Treatment
Focusing on non-addictive pain treatment, Lohocla Research Corporation proceeds to the second phase of their NIDA-funded study with their first-in-class, multi-target therapeutic.

9 June 2021

Lohocla Research to Present at 2021 BIO Digital Conference
Lohocla Research has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event. BIO Digital is scheduled June 10-11 & 14-18, 2021.

1 June 2021

Local Biotech Firm Receives Grant to Attend 2021 BIO Digital Conference
The NIH SEED Program grants Lohocla Research funding to attend the 2021 BIO Digital International Conference

28 Feb 2020

Local Biotech Firm Attracts Substantial NIH Funding for Drug Alternative to Opiates
Focusing on Non-addictive Pain Treatment, Lohocla Research Corporation Attracts National Institute on Drug Abuse Attention with Their Multi-target, Rationally Designed Therapeutic.

Around the Web

2024 Colorado Inno Awards winners revealed

Local Biotech Firm Attracts Substantial NIH Funding for Drug Alternative to Opiates

INDUSTRY LEADERS: Lohocla Research on the Fitzsimons Innovation Campus is innovating fresh new approaches to both pain and addiction

LOHOCLA RESEARCH CORPORATION MOVES FORWARD WITH DEVELOPMENT OF ITS PAIN RELIEVING MEDICATION (Colorado Bioscience Association)

Aurora firm wins $6.5 million NIH grant (Aurora Business Den)

Aurora biotech wins grant for drug to treat alcoholism (Denver Business Journal)

LOHOCLA RESEARCH CORPORATION RECEIVES $6.5 MILLION GRANT TO DEVELOP MEDICATION TO TREAT ALCOHOLISM (Colorado Bioscience Association)

Aurora biotech wins grant for drug to treat alcoholism (9 News Channel)

The Road to Recovery: Perspective from a Small Biotech Firm (International Society for Research on Alcoholism)